Arcus Biosciences Equity 2024

Arcus Biosciences Aktienanalyse

What does Arcus Biosciences do?

Arcus Biosciences Inc is a biotechnology company based in Hayward, California, which focuses on developing novel therapeutics for the treatment of cancer and other serious diseases. The company was founded in 2016 and went public in 2018. Arcus Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Arcus Biosciences's Equity

Arcus Biosciences's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Arcus Biosciences's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Arcus Biosciences's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Arcus Biosciences's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Arcus Biosciences’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Arcus Biosciences Stock

What is the equity of Arcus Biosciences this year?

Arcus Biosciences has equity of 462 M USD this year.

What was the equity of Arcus Biosciences compared to the previous year?

The equity of Arcus Biosciences has increased/decreased by -29.68% decreased compared to the previous year.

What impact does a high equity have on investors of Arcus Biosciences?

A high equity is advantageous for investors of Arcus Biosciences as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Arcus Biosciences?

A low equity can be a risk for investors of Arcus Biosciences, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Arcus Biosciences affect the company?

An increase in equity of Arcus Biosciences can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Arcus Biosciences affect the company?

A reduction in equity of Arcus Biosciences can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Arcus Biosciences?

Some factors that can affect the equity of Arcus Biosciences include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Arcus Biosciences so important for investors?

The equity of Arcus Biosciences is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Arcus Biosciences take to change the equity?

To change equity, Arcus Biosciences can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Arcus Biosciences pay?

Over the past 12 months, Arcus Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arcus Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Arcus Biosciences?

The current dividend yield of Arcus Biosciences is .

When does Arcus Biosciences pay dividends?

Arcus Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Arcus Biosciences?

Arcus Biosciences paid dividends every year for the past 0 years.

What is the dividend of Arcus Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Arcus Biosciences located?

Arcus Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Arcus Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Arcus Biosciences from 6/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Arcus Biosciences pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of Arcus Biosciences in the year 2023?

In the year 2023, Arcus Biosciences distributed 0 USD as dividends.

In which currency does Arcus Biosciences pay out the dividend?

The dividends of Arcus Biosciences are distributed in USD.